# Nektar Therapeutics Inc. (NKTR) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$140M |
| 2024 | -$105M |
| 2023 | -$264M |
| 2022 | -$376M |
| 2021 | -$446M |
| 2020 | -$425M |
| 2019 | -$440M |
| 2018 | $688M |
| 2017 | -$60M |
| 2016 | -$113M |
| 2015 | -$29M |
| 2014 | -$16M |
| 2013 | -$120M |
| 2012 | -$141M |
| 2011 | -$124M |
| 2010 | -$28M |
| 2009 | -$95M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$39M |
| 2025-09-30 | -$32M |
| 2025-06-30 | -$36M |
| 2025-03-31 | -$45M |
| 2024-09-30 | -$34M |
| 2024-06-30 | -$50M |
| 2024-03-31 | -$35M |
| 2023-09-30 | -$45M |
| 2023-06-30 | -$51M |
| 2023-03-31 | -$135M |
| 2022-09-30 | -$54M |
| 2022-06-30 | -$153M |
| 2022-03-31 | -$117M |
| 2021-09-30 | -$114M |
| 2021-06-30 | -$110M |
| 2021-03-31 | -$109M |
| 2020-09-30 | -$103M |
| 2020-06-30 | -$78M |
| 2020-03-31 | -$134M |
| 2019-09-30 | -$99M |
| 2019-06-30 | -$111M |
| 2019-03-31 | -$121M |
| 2018-09-30 | -$99M |
| 2018-06-30 | $974M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/NKTR/operating-income)